Institutional Sign In

Go

Novartis Czech Republic

Novartis Czech Republic's Cash & Cash Equivalents fell 100% yoy to CZK 0 mil in 2017

By Helgi Library - April 2, 2020

Novartis Czech Republic's total assets reached CZK 1,898 mil at the end of 2017, up 9.89% compared to the previous year. ...

Profit Statement
Balance Sheet
Ratios
Cash Flow

Get all company financials in excel:

Download Sample   $19.99

Get all company financials in excel:

Download Sample   $19.99

Finance

Novartis Czech Republic has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2017, or of sales. That’s compared to % average margin seen in last five years.

The company netted in 2017 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.

Novartis Czech Republic’s net debt amounted to at the end of 2017, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.